Ezeprogind sulfate

• CAT Number: I027190
• CAS Number: 1616671-13-6
• Molecular Formula: C25H48N6O8S2
• Molecular Weight: 624.81
• Purity: 98%
• Synonyms: AZP-2006 disulfate; AZP-2006; AZP 2006; AZP2006; Ezeprogind
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: N-[3-[4-[3-[bis(2-methylpropyl)amino]propyl]piperazin-1-yl]propyl]-1H-benzimidazol-2-amine;sulfuric acid
• InChI: InChI=1S/C25H44N6.2H2O4S/c1-21(2)19-31(20-22(3)4)14-8-13-30-17-15-29(16-18-30)12-7-11-26-25-27-23-9-5-6-10-24(23)28-25;2*1-5(2,3)4/h5-6,9-10,21-22H,7-8,11-20H2,1-4H3,(H2,26,27,28);2*(H2,1,2,3,4)
• InChIKey: GIYBNVHXNIZNBZ-UHFFFAOYSA-N
• SMILES: CC(C)CN(CCCN1CCN(CCCNC2=NC3=CC=CC=C3N2)CC1)CC(C)C.O=S(O)(O)=O.O=S(O)(O)=O

Ezeprogind Sulfate(CAT: I027190) is a synthetic compound under investigation for its potential role in neurodegenerative disease research. Although its exact mechanism of action is not fully characterized, it is believed to modulate neuroinflammatory pathways and support neuronal protection. Ezeprogind Sulfate may influence signaling pathways involved in neuroprotection, offering promise in the treatment of conditions such as Alzheimer’s disease and other cognitive disorders. Its application in preclinical studies aims to uncover therapeutic strategies for mitigating neuronal damage, improving cognitive function, and slowing the progression of neurodegenerative diseases.